Lenvatinib: Additional Phase III data

Eisai Co. Ltd. (Tokyo:4523), Tokyo, Japan Product: Lenvatinib ( Lenvima) ( E7080) Business: Cancer Molecular target: Vascular endothelial growth factor (VEGF) receptor; Vascular endothelial growth f...